Inogen Inc — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-03-15

Reporting Person: Bauerlein Alison (EVP, Finance, & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-15	Common Stock	M	18098	$16.62	Acquired	21422	Direct
2021-03-15	Common Stock	S	11586	$52.0127	Disposed	9836	Direct
2021-03-15	Common Stock	S	6512	$52.6103	Disposed	3324	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to Buy)	$16.62	M	18098	Disposed	2021-03-31	Common Stock (18098)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.

F2: Represents the weighted average share price of an aggregate total of 11,586
shares sold in the price range of $51.30 to $52.30 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 6,512
shares sold in the price range of $52.32 to $52.905 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.